HERO Study: Helping Evaluate Reduction in Obesity

Completed

Conditions studied: Obesity

In brief

A prospective, international, multi-center study of clinical outcomes and estimated healthcare resource expenditures associated with the treatment of obesity using the LAP-BAND AP® Adjustable Gastric Banding System.

Key facts

Study ID

NCT00953173

Run by

Apollo Endosurgery, Inc.

People needed

671

Starts

2009-12-01

Expected to finish

2016-10-01

Last updated by the study team

2018-03-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient and investigator have made a decision, independent of the study, to proceed with LAP-BAND AP® implantation.
• Male or female aged ≥ 18 years.
• BMI ≥ 40 or a BMI ≥ 35 with one or more severe co-morbid conditions, or those who are 45.5 Kg / 100 lbs or more over their estimated ideal weight.

You may not qualify if…

• Prior bariatric surgery.
• Type I diabetes patients.
• Participating in another ongoing clinical study with concomitant diagnostic or therapeutic intervention that would reasonably be expected to alter patterns of care, use of medications or the outcomes under study.

Where it is running

• Study site — Everett, Washington, United States
• Study site — Adelaide, South Australia, Australia
• Study site — Jette, Belgium
• Study site — Mississauga, Ontario, Canada
• Study site — Naples, Italy
• Study site — Birmingham, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.